A Comparison of the Immunogenicity and Safety of an Additional Heterologous versus Homologous COVID-19 Vaccination among Non-Seroconverted …
C Nangsue, K Srisurapanont, T Sudjaritruk - Vaccines, 2024 - mdpi.com
This systematic review and meta-analysis aimed to compare the immunogenicity and safety
of an additional heterologous (viral vector) versus homologous (mRNA) COVID-19 vaccine …
of an additional heterologous (viral vector) versus homologous (mRNA) COVID-19 vaccine …
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial
D Mrak, D Sieghart, E Simader, S Tobudic… - Nature …, 2022 - nature.com
Impaired response to COVID-19 vaccination is of particular concern in immunosuppressed
patients. To determine the best vaccination strategy for this vulnerable group we performed …
patients. To determine the best vaccination strategy for this vulnerable group we performed …
Heterologous COVID-19 vaccination as a strategy to accelerate mass immunization
V Klastrup, NB Stærke… - Clinical …, 2022 - clinicalmicrobiologyandinfection …
Conclusion There is still a need for COVID-19 vaccine strategies to evolve, not only to
provide better protection against infection and severe disease, but also to allow for more …
provide better protection against infection and severe disease, but also to allow for more …
Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and …
X Zhang, J Xia, L Jin, Y Wu, X Zheng… - Human Vaccines & …, 2023 - Taylor & Francis
We aimed to evaluate the effectiveness or efficacy of heterologous or homologous COVID-
19 vaccine regimens against COVID-19-related outcomes after primary immunization with …
19 vaccine regimens against COVID-19-related outcomes after primary immunization with …
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
ARYB Lee, SY Wong, LYA Chai, SC Lee, MX Lee… - Bmj, 2022 - bmj.com
Objective To compare the efficacy of covid-19 vaccines between immunocompromised and
immunocompetent people. Design Systematic review and meta-analysis. Data sources …
immunocompetent people. Design Systematic review and meta-analysis. Data sources …
Anti-SARS-CoV-2 spike IgG following injection of the third dose vaccine: A systematic review with meta-analysis of heterologous versus homologous vaccination
Background The mass vaccination is a key strategy to prevent and control the coronavirus
disease 2019 (COVID-19) pandemic. Today, several different types of vaccines against …
disease 2019 (COVID-19) pandemic. Today, several different types of vaccines against …
Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA …
M Bonelli, D Mrak, S Tobudic, D Sieghart, M Koblischke… - MedRxiv, 2021 - medrxiv.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-induced coronavirus
disease 2019 (COVID-19) has led to exponentially rising mortality, particularly in …
disease 2019 (COVID-19) has led to exponentially rising mortality, particularly in …
Catch-up antibody responses and hybrid immunity in mRNA vaccinated patients at risk of severe COVID-19
Background The immunogenicity of repeated vaccination and hybrid immunity in vulnerable
patients remains unclear. Methods We studied the impact of iterative Covid-19 mRNA …
patients remains unclear. Methods We studied the impact of iterative Covid-19 mRNA …
Effectiveness of bivalent mRNA vaccines against medically attended symptomatic SARS-CoV-2 infection and COVID-19-related hospital admission among SARS-CoV …
Background Emergence of the SARS-CoV-2 omicron (B. 1.1. 529) variant with high immune
evasion has led to the development and roll-out of bivalent mRNA vaccines targeting …
evasion has led to the development and roll-out of bivalent mRNA vaccines targeting …
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
MM Mehrabi Nejad, F Moosaie… - European journal of …, 2022 - Springer
Background Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2
infection, morbidity, and mortality compared to the general population. They should be …
infection, morbidity, and mortality compared to the general population. They should be …
相关搜索
- meta analysis immunocompromised patients
- homologous vaccination dose vaccine
- mrna vaccines immunocompromised patients
- sars cov mrna vaccination
- covid 19 patients at risk
- homologous mrna booster vaccination
- homologous vaccination spike igg
- homologous vaccination meta analysis
- immunosuppressed patients mrna vaccination
- sars cov immunosuppressed patients
- covid 19 antibody responses
- antibody seroconversion mrna vaccination
- covid 19 hybrid immunity
- sars cov booster vaccination
- immunosuppressed patients booster vaccination